ATE43139T1 - Klonierungs- und expressionsvektoren fuer gammainterferon, transformierte bakterien und verfahren zur herstellung von gamma-interferon. - Google Patents
Klonierungs- und expressionsvektoren fuer gammainterferon, transformierte bakterien und verfahren zur herstellung von gamma-interferon.Info
- Publication number
- ATE43139T1 ATE43139T1 AT84402502T AT84402502T ATE43139T1 AT E43139 T1 ATE43139 T1 AT E43139T1 AT 84402502 T AT84402502 T AT 84402502T AT 84402502 T AT84402502 T AT 84402502T AT E43139 T1 ATE43139 T1 AT E43139T1
- Authority
- AT
- Austria
- Prior art keywords
- gamma interferon
- cloning
- methods
- expression vectors
- transformed bacteria
- Prior art date
Links
- 102000008070 Interferon-gamma Human genes 0.000 title abstract 4
- 108010074328 Interferon-gamma Proteins 0.000 title abstract 4
- 229940044627 gamma-interferon Drugs 0.000 title abstract 4
- 241000894006 Bacteria Species 0.000 title abstract 3
- 238000010367 cloning Methods 0.000 title 1
- 230000016396 cytokine production Effects 0.000 title 1
- 239000013604 expression vector Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 239000013598 vector Substances 0.000 abstract 2
- 239000013612 plasmid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/73—Expression systems using phage (lambda) regulatory sequences
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8319777A FR2556365B1 (fr) | 1983-12-09 | 1983-12-09 | Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g |
| EP84402502A EP0146462B1 (de) | 1983-12-09 | 1984-12-05 | Klonierungs- und Expressionsvektoren für gamma-Interferon, transformierte Bakterien und Verfahren zur Herstellung von gamma-Interferon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE43139T1 true ATE43139T1 (de) | 1989-06-15 |
Family
ID=9295048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT84402502T ATE43139T1 (de) | 1983-12-09 | 1984-12-05 | Klonierungs- und expressionsvektoren fuer gammainterferon, transformierte bakterien und verfahren zur herstellung von gamma-interferon. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5081022A (de) |
| EP (1) | EP0146462B1 (de) |
| JP (1) | JPS61500588A (de) |
| AT (1) | ATE43139T1 (de) |
| CA (1) | CA1245584A (de) |
| DE (1) | DE3478230D1 (de) |
| FR (1) | FR2556365B1 (de) |
| WO (1) | WO1985002624A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4855238A (en) | 1983-12-16 | 1989-08-08 | Genentech, Inc. | Recombinant gamma interferons having enhanced stability and methods therefor |
| FR2598430B1 (fr) * | 1986-05-06 | 1990-02-02 | Roussel Uclaf | Nouveaux vecteurs d'expression, leur procede d'obtention et leur application pour exprimer une proteine quelconque dans escherichia coli |
| ATE129285T1 (de) * | 1986-08-05 | 1995-11-15 | Transgene Sa | Verfahren zur stabilisierung eines plasmids, das in einem bakterienstamm enthalten ist und der erhaltene stamm. |
| JPH07163368A (ja) * | 1993-12-15 | 1995-06-27 | Hayashibara Biochem Lab Inc | 組換えdnaとその組換えdnaを含む形質転換体 |
| DK1368483T3 (da) | 2001-03-09 | 2012-11-05 | Genentech Inc | Fremgangsmåde til fremstilling af polypeptider |
| US8778880B2 (en) | 2004-02-02 | 2014-07-15 | Ambrx, Inc. | Human growth hormone modified at position 35 |
| AU2008201682B2 (en) * | 2004-02-02 | 2011-02-24 | Ambrx, Inc. | Modified human interferon polypeptides and their uses |
| CA2663986C (en) * | 2006-09-21 | 2013-06-25 | Asahi Kasei Chemicals Corporation | Wastewater treatment method |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE63126B1 (en) * | 1980-06-06 | 1995-03-22 | Biogen Inc | Improved vectors and methods for making such vectors and for expressing cloned genes |
| AU561343B2 (en) * | 1981-10-19 | 1987-05-07 | Genentech Inc. | Human immune interferon by recombinant dna |
| IL68100A0 (en) * | 1982-03-24 | 1983-06-15 | Takeda Chemical Industries Ltd | Novel dna and use thereof |
| US6936694B1 (en) * | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
| FR2526661B1 (fr) * | 1982-05-13 | 1986-02-21 | Transgene Sa | Nouveaux vecteurs d'expression de la proteine antigenique de la rage et leur application a la preparation de vaccins |
| JPH0787797B2 (ja) * | 1982-05-20 | 1995-09-27 | サントリー株式会社 | ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法 |
| US4582800A (en) * | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
| WO1984002129A1 (fr) * | 1982-11-22 | 1984-06-07 | Takeda Chemical Industries Ltd | Proteine de l'interferon immun humain et son procede de preparation |
| US4578355A (en) * | 1983-01-12 | 1986-03-25 | The United States Of America As Represented By The Department Of Health And Human Services | Plasmid cloning vector pAS1 |
-
1983
- 1983-12-09 FR FR8319777A patent/FR2556365B1/fr not_active Expired
-
1984
- 1984-12-05 AT AT84402502T patent/ATE43139T1/de not_active IP Right Cessation
- 1984-12-05 WO PCT/FR1984/000287 patent/WO1985002624A1/fr not_active Ceased
- 1984-12-05 EP EP84402502A patent/EP0146462B1/de not_active Expired
- 1984-12-05 DE DE8484402502T patent/DE3478230D1/de not_active Expired
- 1984-12-05 JP JP59504503A patent/JPS61500588A/ja active Pending
- 1984-12-07 CA CA000469594A patent/CA1245584A/fr not_active Expired
-
1989
- 1989-06-02 US US07/360,305 patent/US5081022A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0146462A3 (en) | 1985-08-14 |
| FR2556365A1 (fr) | 1985-06-14 |
| EP0146462B1 (de) | 1989-05-17 |
| DE3478230D1 (en) | 1989-06-22 |
| CA1245584A (fr) | 1988-11-29 |
| WO1985002624A1 (fr) | 1985-06-20 |
| JPS61500588A (ja) | 1986-04-03 |
| FR2556365B1 (fr) | 1987-07-31 |
| EP0146462A2 (de) | 1985-06-26 |
| US5081022A (en) | 1992-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG19101A (en) | Process for preparing of expression of human proapolipoprotein A.1. | |
| EP0722461A4 (de) | Expression eines fusionspolypeptides, das ohne leadersequenz aus dem cytoplasma transportiert wird | |
| ATE54167T1 (de) | Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden. | |
| ATE192500T1 (de) | Rekombinante viren vektoren zur expression in muskelzellen | |
| DE3177106D1 (en) | Hybrid human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them | |
| ATE43635T1 (de) | Verfahren zur herstellung von interferon und expressionsvektoren dafuer. | |
| ES2181674T3 (es) | Dominios de union en las proteinas notch y delta. | |
| DE3586189D1 (de) | Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute. | |
| ATE43139T1 (de) | Klonierungs- und expressionsvektoren fuer gammainterferon, transformierte bakterien und verfahren zur herstellung von gamma-interferon. | |
| ES8107307A1 (es) | Un procedimiento de preparacion de un vector de transferen- cia de adn | |
| NZ241829A (en) | Oxalate oxidase, genes encoding it, vectors and transformed plants | |
| ATE166390T1 (de) | Anti-katze immundefiziensvirus (fiv) impfstoffe | |
| EP0072541A3 (de) | Menschliche Leukozyten-Interferone, Verfahren zu deren Mikrobiologischer Herstellung, Zwischenprodukte und diese enthaltende Zusammensetzungen | |
| ATE233321T1 (de) | Verbesserungen in der herstellung von proteinen in wirtszellen | |
| JPS5756495A (en) | Novel dna-introduction vector and recombinant dna | |
| DE69031996D1 (de) | Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |